ABHD10 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.316500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.971400E-01
Normal-vs-Stage2
4.202200E-01
Normal-vs-Stage3
2.069400E-01
Normal-vs-Stage4
5.092200E-01
Stage1-vs-Stage2
8.093900E-02
Stage1-vs-Stage3
6.940500E-02
Stage1-vs-Stage4
2.589000E-01
Stage2-vs-Stage3
2.753400E-01
Stage2-vs-Stage4
4.938800E-01
Stage3-vs-Stage4
3.828000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.117580E-01
Normal-vs-AfricanAmerican
2.997800E-01
Normal-vs-Asian
3.780400E-01
Caucasian-vs-AfricanAmerican
8.599000E-01
Caucasian-vs-Asian
1.046230E-01
AfricanAmerican-vs-Asian
6.490000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.310800E-01
Normal-vs-Female
1.868600E-01
Male-vs-Female
1.397630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.938800E-01
Normal-vs-Age(41-60Yrs)
4.930800E-01
Normal-vs-Age(61-80Yrs)
8.672200E-02
Normal-vs-Age(81-100Yrs)
2.699000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.440200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.862200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.932600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.159400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.338200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.601000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.949800E-01
Normal-vs-Daily Drinker
1.514360E-01
Normal-vs-Weekly Drinker
3.339600E-01
Normal-vs-Occasional Drinker
5.236400E-01
Normal-vs-Social Drinker
3.311400E-01
Non Drinker-vs-Daily Drinker
4.775800E-01
Non Drinker-vs-Weekly Drinker
2.891000E-01
Non Drinker-vs-Occasional Drinker
1.295050E-01
Non Drinker-vs-Social Drinker
1.481770E-01
Daily Drinker-vs-Weekly Drinker
1.232250E-01
Daily Drinker-vs-Occasional Drinker
3.035800E-01
Daily Drinker-vs-Social Drinker
4.852200E-01
Weekly Drinker-vs-Occasional Drinker
4.033800E-02
Weekly Drinker-vs-Social Drinker
5.156100E-02
Occasional Drinker-vs-Social Drinker
7.247600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.353170E-01
Normal-vs-Grade 2
5.224400E-03
Normal-vs-Grade 3
1.186180E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.426000E-01
Grade 1-vs-Grade 3
6.111200E-01
Grade 1-vs-Grade 4
1.353170E-01
Grade 2-vs-Grade 3
3.572800E-01
Grade 2-vs-Grade 4
5.224400E-03
Grade 3-vs-Grade 4
1.186180E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.799800E-01
Normal-vs-NonDiabetic
1.206380E-01
Diabetic-vs-NonDiabetic
7.803700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.820800E-01
Normal-vs-NoPancreatitis
4.559400E-01
Pancreatitis-vs-NoPancreatitis
4.290200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.267800E-01
Normal-vs-N1
4.277600E-01
N0-vs-N1
8.608400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.540600E-01
Normal-vs-TP53-NonMutant
4.920600E-01
TP53-Mutant-vs-TP53-NonMutant
2.100600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
